Using Halal Gelatin and Gelatinous Substitutes in Pharmaceutical Preparations

Nurhusna Samsudin (), Amal A. M. Elgharbawy () and Walaa A. Abualsunun ()
Additional contact information
Nurhusna Samsudin: International Islamic University Malaysia (IIUM)
Amal A. M. Elgharbawy: International Islamic University Malaysia (IIUM)
Walaa A. Abualsunun: King Abdulaziz University

Chapter Chapter 12 in Solving Halal Industry Issues Through Research in Halal Sciences, 2024, pp 195-213 from Springer

Abstract: Abstract Gelatin is a versatile biomaterial integral to various industries, particularly pharmaceuticals, where its unique properties are leveraged to enhance drug efficacy and patient compliance. Derived from the irreversible transformation of collagen, gelatin exhibits commendable characteristics such as remarkable biocompatibility, which allows it to coexist with living tissues without eliciting adverse reactions. Its biodegradability facilitates natural breakdown within the body, making it ideal for drug delivery systems and tissue engineering scaffolds. Non-immunogenicity ensures it does not provoke immune responses, minimizing complications in medical applications. The malleability of gelatin enables its manipulation into films, gels, and microspheres, thus providing versatility for drug delivery systems. Its widespread availability and cost-effectiveness make it an attractive material for pharmaceutical companies. Nonetheless, the issue arises concerning whether gelatin can be embraced by individuals adhering to Islamic dietary guidelines, as a substantial body of research suggests its primary sourcing from animal by-products, particularly those derived from pigs. Consequently, while acknowledging the commendable attributes, diverse applications, and challenges within the pharmaceutical industry related to gelatin, this chapter underscores the importance of exploring Halal gelatin as a viable alternative and substitute in the pharmaceutical sector.

Keywords: Halal; Gelatin; Biocompatibility; Biodegradability; Drug delivery systems; Pharmaceutical applications (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-97-3843-4_12

Ordering information: This item can be ordered from
http://www.springer.com/9789819738434

DOI: 10.1007/978-981-97-3843-4_12

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().